Loading...
•
Jun 30, 2024
Safety Shot Q4 2024 Earnings Report
Safety Shot Q4 2024 Earnings Report
Key Takeaways
Safety Shot, Inc. reported a net loss of $49,409,632 for the fiscal year ended December 31, 2024, with total revenues of $701,967. The company continues to incur significant costs in pursuit of its expansion and development plans, raising substantial doubt about its ability to continue as a going concern.
The company reported a net loss of $49,409,632 for the fiscal year ended December 31, 2024.
Total revenues for the fiscal year ended December 31, 2024, were $701,967, an increase from $202,670 in the previous year.
The company's accumulated deficit reached $115,090,347 as of December 31, 2024.
The auditors have included a going concern opinion in the annual report due to significant costs and operating losses.
Safety Shot
Safety Shot
Safety Shot Revenue by Segment
Safety Shot Revenue by Geographic Location
Revenue by Segment
Dietary Drink Supplement Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.com Forward Guidance
The company plans to continue its expansion and development, including new product flavors and additional research studies for the Sure Shot Dietary Supplement. They also anticipate continued investment in marketing and brand development.
Positive Outlook
- Plans to develop new flavors for current SKUs (12oz., 4 oz. and Stick Pack) of Sure Shot Dietary Supplement.
- Intends to conduct additional research studies in Q2 and Q3 of 2025 to assess varying dosages and effects on BAC.
- Continued investment in marketing and brand development efforts, including digital platforms, sponsorships, collaborations, and retail partnerships.
- Strategic alliances with established industry players for high-quality raw materials.
- Seeking to collaborate with other companies to license intellectual property for additional revenue streams and global expansion.
Challenges Ahead
- Uncertainty regarding the company's ability to continue as a going concern due to significant costs and operating losses.
- Potential for rapid technological changes to make products obsolete.
- Intense competition in the wellness drink market and other target markets.
- Subject to extensive government regulations, with potential for new or changed laws to increase costs or limit sales.
- Reliance on third-party manufacturers and clinical trial organizations, which could lead to supply issues or delays.